EP

Pharmaceutical products targeting selected biological pathways, namely, for the treatment of autoimmune and neurodegenerative diseases and for use in organ and cellular transplantation

Pharmaceutical research and development and medical research and development in the field of autoimmune and neurodegenerative diseases